MENU

Why Lifehealthcare Group Ltd shares jumped 41% higher today

In morning trade the Lifehealthcare Group Ltd (ASX: LHC) share price has defied the market sell-off and stormed higher.

At the time of writing the healthcare solutions provider’s shares are up 41% to $3.63.

Why are its shares higher?

As I explained yesterday, LifeHealthcare’s shares have been in a trading halt pending an announcement regarding a takeover approach.

This morning the company has confirmed that it has entered into a binding scheme implementation deed with Pacific Equity Partners after receiving a takeover offer of $3.75 per share in cash. This equates to a premium of almost 46% from the last close price and values the company at $179 million.

LifeHealthcare’s directors have unanimously recommended that shareholders vote in favour of the scheme, in the absence of a superior proposal and subject to an independent expert concluding that it is in the best interests of shareholders.

What about the dividend?

LifeHealthcare has been one of my favourite shares in the healthcare sector over the last 12 months due to its solid growth prospects and generous dividend.

The good news for existing shareholders is that the company is still able to declare an interim dividend when it announces its results on February 20. However, the takeover price will be reduced accordingly.

In addition to this, management has advised that it intends to declare a fully franked special dividend of 18 cents per share if the scheme goes ahead. Once again, this would reduce the takeover price.

What now?

I think this is a good deal and if I were a shareholder I would vote in favour of it. Investors that aren’t bothered about the dividends might want to consider selling today and reinvesting the funds elsewhere. Especially with a number of healthcare shares sinking lower this week amid the market sell off.

I would consider buying Nanosonics Ltd (ASX: NAN), National Veterinary Care Ltd (ASX: NVL), or Zenitas Healthcare Ltd (ASX: ZNT).

Alternatively, shareholders could reinvest these funds into these exciting growth shares which I'm tipping to smash the market this year.

Top 3 ASX Blue Chips To Buy In 2018

For many, blue chip stocks mean stability, profitability and regular dividends, often fully franked..

But knowing which blue chips to buy, and when, can be fraught with danger.

The Motley Fool's in-house analyst team has poured over thousands of hours worth of proprietary research to bring you the names of "The Motley Fool's Top 3 Blue Chip Stocks for 2018."

Each one pays a fully franked dividend. Each one has not only grown its profits, but has also grown its dividend. One increased it by a whopping 33%, while another trades on a grossed up (fully franked) dividend yield of almost 7%.

The names of these Top 3 ASX Blue Chips are included in this specially prepared free report. But you will have to hurry. Depending on demand - and how quickly the share prices of these companies moves - we may be forced to remove this report.

Click here to claim your free report.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of and has recommended Nanosonics Limited. The Motley Fool Australia owns shares of NATVETCARE FPO. The Motley Fool Australia has recommended Zenitas Healthcare Ltd. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

Two New Stock Picks Every Month!

Not to alarm you, but you’re about to miss a very important event! Chief Investment Advisor Scott Phillips and his team at Motley Fool Share Advisor are about to reveal their latest official stock recommendation. The premium “buy alert” will be unveiled to members and you can be among the first to act on the tip.

Don’t let this opportunity pass you by – this is your chance to get in early!

Simply enter your email now to find out how you can get instant access.

By clicking this button, you agree to our Terms of Service and Privacy Policy. We will use your email address only to keep you informed about updates to our website and about other products and services we think might interest you. You can unsubscribe from Take Stock at anytime. Please refer to our Financial Services Guide (FSG) for more information.